News
Study says MS drugs from Biogen, Bayer too expensive in US - The...
archive.boston.com
Biogen Idec Inc. and Bayer AG would have to cut the price of their multiple sclerosis drugs by at least two-thirds in the United States to make them cost...
Benefit of MS drugs comes at steep price: study - Reuters
www.reuters.com
The figure for DMDs is an "order of magnitude higher," said Katia Noyes, a researcher at the University of Rochester in New York who led the ...
Study Examines High Drug Costs vs. Benefits for M.S. Patients - The...
prescriptions.blogs.nytimes.com
A new study finds the costs of bio-tech drugs for treating multiple sclerosis about 10 times more than what would be considered cost-effective.
MICHELLE TEA & KATIA NOYES | Bookshop Santa Cruz
www.bookshopsantacruz.com
MICHELLE TEA & KATIA NOYES. MICHELLE TEA, whose gritty, personal writing has earned her top accolades, returns to Bookshop Santa Cruz to read and ...
sorted by relevance / date